Stockholders’ equity (deficit) (Details Narrative)
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
Apr. 07, 2026
shares
|
Jan. 16, 2026
shares
|
Jan. 01, 2026
USD ($)
|
Apr. 28, 2025
shares
|
Jan. 21, 2025
shares
|
Jan. 03, 2025 |
Feb. 29, 2024 |
Jan. 31, 2026
USD ($)
shares
|
Feb. 28, 2025
shares
|
Jun. 30, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2026
shares
|
Jun. 30, 2025
USD ($)
|
Mar. 31, 2025
shares
|
Jun. 30, 2026
USD ($)
Integer
$ / shares
shares
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
$ / shares
shares
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
|
10,000,000
|
|
10,000,000
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
0
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
0
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
490,000,000
|
|
|
|
490,000,000
|
|
490,000,000
|
|
| Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
1,295,234
|
|
|
|
1,295,234
|
|
117,780
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
1,295,234
|
|
|
|
1,295,234
|
|
117,780
|
|
| General and administrative expenses | $ |
|
|
|
|
|
|
|
|
|
|
$ 970,211
|
|
$ 395,692
|
|
$ 1,990,668
|
$ 15,469,240
|
|
|
| Arena Business Solutions Global SPC II Ltd [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional payment of commitment fee shares |
|
|
|
|
|
|
|
|
207
|
|
|
|
|
|
|
|
|
|
| Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion amount | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 9,523,683
|
|
| Number of shares issued upon debt conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73,998
|
|
| Aspire Biopharma Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
91,500,000
|
|
|
|
|
|
|
|
|
|
|
|
91,500,000
|
| Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.40
|
| Number of warrants issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,000,000
|
| Common stock issued upon warrant conversion |
|
|
4,780
|
|
|
91,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued to affiliated company |
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
1,385
|
|
|
|
|
| Issuance of Series A Convertible Preferred Stock, shares |
[2] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon debt conversion |
|
|
|
|
|
|
|
|
1,625
|
|
|
|
|
|
|
|
|
|
| Remaining debt converted into common stock, value | $ |
|
|
|
|
|
|
|
|
$ 163,817
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon debt conversion |
|
|
|
|
|
|
|
|
1,625
|
|
|
|
|
|
|
|
|
|
| Remaining debt converted into common stock, value | $ |
|
|
|
|
|
|
|
|
$ 163,817
|
|
|
|
|
|
|
|
|
|
| Corporate Advisory Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares outstanding percentage |
|
|
|
|
|
|
4.75%
|
6.00%
|
|
|
|
|
|
|
|
|
|
|
| Shares issued to affiliated company |
|
|
|
|
|
|
|
|
|
1,385
|
|
|
|
|
|
|
|
|
| Business combination shares |
|
|
|
|
|
|
|
|
|
29,167
|
|
|
|
|
|
|
|
|
| General and administrative expenses | $ |
|
|
|
|
|
|
|
|
|
|
$ 157,000
|
|
$ 0
|
|
$ 157,000
|
$ 14,131,250
|
|
|
| Settlement Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of Series A Convertible Preferred Stock, shares |
|
|
|
|
521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Purchase Agreement [Member] | Common Stock [Member] | Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of Series A Convertible Preferred Stock, shares |
|
5,000
|
|
|
|
|
|
|
26,333
|
|
|
|
|
|
|
|
|
|
| Exchange Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion amount | $ |
|
|
|
$ 1,750,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued upon debt conversion |
|
|
|
|
|
|
|
|
21,525
|
|
|
|
|
|
|
|
|
|
| Exchange description |
|
|
|
upon a financing in excess of $3,000,000 (a “Financing”), the Company may repay part or all of any Holder’s
Outstanding Balance. Upon a Financing, a Holder may elect to receive cash proceeds from any Financing in an amount equal to twenty five
percent (25%) of such Holder’s Outstanding Balance, to be applied to such Holder’s Outstanding Balance. If a Holder elects
to require any part of its Outstanding Balance to be repaid from the proceeds of a Financing, it can elect to receive up to 33.33% of
the aggregate proceeds of such Financing.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
14,374,696
|
|
|
|
14,374,696
|
|
14,374,969
|
|
| Public warrant exercisable term |
|
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
30 days
|
|
|
|
| Redemption price per public warrant | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 12
|
|
|
|
| Redemption period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 days
|
|
|
|
| Warrant redemption condition minimum share price | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 21,600
|
|
|
|
| Threshold trading days for redemption of public warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 days
|
|
|
|
| Threshold consecutive trading days for redemption of public warrants | Integer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
|
|
|
|
| Private Placement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
8,199
|
|
|
|
8,199
|
|
8,199
|
|
| Series A Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
30,000
|
|
0
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
17,050
|
|
|
|
17,050
|
|
0
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
17,050
|
|
|
|
17,050
|
|
0
|
|
| Common Class A [Member] | Public Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
1,200
|
|
|
|
1,200
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 13,800
|
|
|
|
$ 13,800
|
|
|
|
| Common Class A [Member] | Private Placement Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 8,199
|
|
|
|
$ 8,199
|
|
|
|
|
|